Recent studies have unveiled novel mechanisms contributing to the pathogenesis of calcific aortic valve disease (CAVD) and have highlighted the potential role of PGRN as a mediator of valve fibrosis and osteoblastic differentiation [75]. This evidence concerns the gene GRN and congenital bilateral aplasia of vas deferens from CFTR mutation.